To include your compound in the COVID-19 Resource Center, submit it here.
A U.K. Phase Ib/II trial in 55 HIV-positive patients who have not yet required antiretroviral therapy showed
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury